Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
GLP-1 medications like semaglutide are not recommended for individuals with a history of: Medullary thyroid carcinoma (or a family history of it) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Pancreatitis or gallbladder disease Severe gastrointestinal disorders FuturHealth clinicians screen all patients for these risk factors during the onboarding process
The study received a lot of press
The gradual titration schedule allows your body to adapt to the medication while you learn injection technique and monitor your blood sugar response
It can also help in making informed decisions about their treatment options and in having meaningful discussions with their healthcare providers
GLP-1 helps increase insulin production, which lowers blood sugar, while GIP helps reduce the amount of sugar released by the liver
Numbers shown are illustrative averages from MGMA and HFMA benchmarks plus Staffingly client averages
